VACCINE TECHNOLOGIES INTERNATIONAL
Vaccine Technologies International is a biotech company headquartered in Grand Cayman.
VACCINE TECHNOLOGIES INTERNATIONAL
Industry:
Biopharma Biotechnology Health Care Medical Medical Device
Address:
Grand Cayman, Midland, Cayman Islands
Country:
Cayman Islands
Total Employee:
1+
Status:
Active
Total Funding:
17.75 M USD
Similar Organizations
Applied Spine Technologies
Applied Spine Technologies offers spine stabilization systems that support patients with an injured or degenerated spine.
ArmRX
AmEx offers water protective leg and arm gloves.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Brogent International
Brogent International is a genomics and bioinformatics healthcare company that pioneers in bioinformatics and artificial intelligence.
Cambridge Antibody Technology
Cambridge Antibody Technology was a biotechnology company headquartered in Cambridge, England.
Confirma
Confirma facilitates MRI study analysis and reporting through an automated and standardized process.
HaimaChek
Detect cancer earlier than with every other method on the market to support early diagnosis and treatment.
MESH Interactive Agency
MESH Interactive Agency is a digital marketing and advertising company.
Sable Systems International
Sable Systems International is a biotechnology company for precision metabolic measurement.
More informations about "Vaccine Technologies International"
Home - Vaccine and Infectious Disease Organization
Apr 30, 2025 Protecting the world from infectious diseases has never been more urgent. The Vaccine and Infectious Disease Organization (VIDO) is a โฆSee details»
International Vaccine Institute - Wikipedia
As of January 2019, IVI includes 35 countries and the World Health Organization (WHO) as signatories to its Establishment Agreement: Bangladesh, Bhutan, Brazil, China, Ecuador, Egypt, India, Indonesia, Israel, Jamaica, Kazakhstan Kyrgyzstan, Lebanon, Liberia, Malta, Mongolia, Myanmar, Nepal, Netherlands, Oman, Pakistan, Panama, Papua New Guinea, Peru, Philippines, Republic of Korea, Romania, Senegal, Sri Lanka, Sweden, and the World Health Organization. See details»
Home page | CEPI
May 28, 2025 CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector โฆSee details»
Vaccines - PATH
We advance vaccines through every stage of development and create technologies and strategies to help countries deliver them. ... the World Health โฆSee details»
Exploring Future Pandemic Preparedness Through the โฆ
Jan 10, 2025 The vaccine support programs of international organizations such as the WHO, CEPI, GAVI, and IVI, which have specialized areas in pandemic โฆSee details»
International Organizations, Vaccine Manufacturers โฆ
Sep 16, 2021 The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization met with the CEOs โฆSee details»
Vaccine technology transfer in a global health crisis: Actors ...
For all of the attention given to tracking and debating the extent of international vaccine technology transfer, we know little about what has happened โ how partnerships were โฆSee details»
Gavi, the Vaccine Alliance
Gavi's high-level pledging summit, to be co-hosted by the European Union and the Gates Foundation, seeks to raise at least US$ 9 billion from our donors to โฆSee details»
Vaccine Development Technology ROADMAP - World Health โฆ
Suggested citation. Group A Streptococcus Vaccine Development Technology Roadmap: Priority activities for develop - ment, testing, licensure and global availability of group A Streptococcus โฆSee details»
Increasing Access to Vaccines Through Technology Transfer and โฆ
โข For technology transfer to be attractive and successful, a winโwin condition is required, which is facilitated by a commitment from the government to support the technology transfer or a large โฆSee details»
IVI partners with Global Vaccine Leading Technology โฆ
November 22, 2022, SEOUL, Republic of Korea โ The Global Vaccine Leading Technology Center (GVL) in the Republic of Korea and the International โฆSee details»
Vaccine technology transfer in a global health crisis: Actors ...
May 1, 2023 With technology transfer for local production widely regarded by scholars, activists, and international organizations as essential for addressing COVID-19 and future global health โฆSee details»
World Health Organization Medical products, vaccinations and โฆ
The safety and availability of blood supplies have direct implications for public health, but the organization, capacity and safety standards of national blood and health services vary widely โฆSee details»
Vaccine Technologies and Platforms for Infectious Diseases: โฆ
This technology has been used to develop several licensed vaccines such as the human papillomavirus vaccine and is being explored against Chikungunya, ZIKV, and SARS-CoV-2 โฆSee details»
Exploring Future Pandemic Preparedness Through the โฆ
Jan 10, 2025 Methods: This study focused on vaccine platform technology and the key roles of international organizations in the pandemic crisis. Literature data on vaccine platform โฆSee details»
Challenges implementing technology transfer as a viable pathway โฆ
May 27, 2025 In September 2021 (WHO, Citation 2022), while the hub was still working on its vaccines, representatives from these countriesโ selected recipient entities were at the hub to โฆSee details»
Technology for global immunisation - The Lancet Digital Health
May 16, 2025 Immunisation stands as one of the most crucial and cost-effective public health interventions, substantially reducing the global burden of infectious diseases and saving โฆSee details»
Science & Tech Spotlight: Universal Vaccines | U.S. GAO
May 22, 2025 Vaccines can help prevent or contain outbreaks of existing and future virus strands, resulting in economic and societal benefits. For example, COVID-19 and the โฆSee details»
International Collaboration to Ensure Equitable Access to Vaccines โฆ
The participation of funded countries has been supported by the Gavi COVAX Advance Market Commitment (AMC), a financing instrument designed to support the procurement and delivery โฆSee details»
mRNA Technology Transfer (mRNA TT) Programme
Programme partners receive know-how, technology and training from the hub. Partners should be able to share expertise and improvements with others in the network in the longer term. โฆSee details»